Cargando…
Retreatment with immune checkpoint inhibitors in solid tumors: a systematic review
BACKGROUND: A large proportion of patients eventually experience disease progression despite treatment with immune checkpoint inhibitors (ICIs), but subsequent treatment options are limited for this population. Retreatment with the same or different types of ICIs is a possible strategy, but the clin...
Autores principales: | Yang, Kaili, Li, Jiarui, Sun, Zhao, Zhao, Lin, Bai, Chunmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705192/ https://www.ncbi.nlm.nih.gov/pubmed/33294036 http://dx.doi.org/10.1177/1758835920975353 |
Ejemplares similares
-
Immune checkpoint inhibitors in advanced or metastatic mucosal
melanoma: a systematic review
por: Li, Jiarui, et al.
Publicado: (2020) -
The Effectiveness of Cancer Immune Checkpoint Inhibitor Retreatment and Rechallenge—A Systematic Review
por: Perdyan, Adrian, et al.
Publicado: (2023) -
Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer Patients With Different Metastatic Sites: A Systematic Review and Meta-Analysis
por: Yang, Kaili, et al.
Publicado: (2020) -
Clinicopathological Features of Kidney Injury Related to Immune Checkpoint Inhibitors: A Systematic Review
por: Xu, Ling-Yi, et al.
Publicado: (2023) -
Neoadjuvant Immune Checkpoint Inhibitors for Resectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Zhao, Mei, et al.
Publicado: (2023)